ARCB vs JBLU

ArcBest Corporation's Piotroski F-Score of 4/9 indicates weak financial health, signaling deterioration in operational efficiency and profitability. The absence of an Altman Z-Score raises concern about potential distress risk, especially given a current ratio of 0.95 and quick ratio of 0.79, both below safe thresholds. Despite a seemingly attractive forward P/E of 11.68, the company exhibits negative revenue growth (-2.90% YoY) and severe earnings declines (YoY EPS down 72.9%), undermining long-term sustainability. The Graham Number of $58.46 suggests a defensive fair value, yet the stock trades at $84.87—over 44% above this benchmark—indicating significant overvaluation. Analysts' 'buy' recommendation appears misaligned with deteriorating fundamentals.

JetBlue exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a lack of a viable Graham Number due to negative earnings. The company is heavily leveraged with a Debt/Equity ratio of 4.44 and faces significant liquidity pressure with a Current Ratio of 0.74. While the stock trades at a discount to book value (P/B 0.83), negative revenue growth and a catastrophic YoY EPS decline of -276.9% suggest a failing fundamental trajectory. Recent price gains appear speculative as they diverge from the deteriorating balance sheet and a target price ($4.49) that sits below the current market price.